Sympathetic activation triggers systemic interleukin-10 release in immunodepression induced by brain injury

Nat Med. 1998 Jul;4(7):808-13. doi: 10.1038/nm0798-808.

Abstract

The mechanism of immunodepression after brain injury is not yet clear. Here we demonstrate rapid systemic release of the immunoinhibitory cytokine interleukin-10, monocytic deactivation and a high incidence of infection in patients with 'sympathetic storm' due to acute accidental or iatrogenic brain trauma. In vitro studies showed that within minutes catecholamines trigger the secretion of interleukin-10 from unstimulated monocytes through a beta-adrenoreceptor-mediated, cAMP/protein kinase A-dependent pathway. We found that in a rat model of acute brain injury, the beta-receptor antagonist propranolol prevented the increase of interleukin-10 plasma levels. Rapid monocytic interleukin-10 release after sympathetic activation may represent a common pathway for immunodepression induced by stress and injury.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenergic beta-Antagonists / pharmacology
  • Adult
  • Aged
  • Animals
  • Brain / surgery
  • Brain Injuries / blood*
  • Brain Injuries / complications
  • Brain Injuries / physiopathology
  • Brain Neoplasms / blood
  • Brain Neoplasms / surgery
  • Brain Stem / physiopathology
  • Catecholamines / pharmacology
  • Humans
  • Immune Tolerance*
  • Interleukin-10 / blood*
  • Male
  • Middle Aged
  • Neoplasms, Nerve Tissue / blood
  • Neoplasms, Nerve Tissue / surgery
  • Propranolol / pharmacology
  • Rats
  • Rats, Sprague-Dawley
  • Sympathetic Nervous System / drug effects
  • Sympathetic Nervous System / physiopathology*
  • Sympatholytics / pharmacology
  • Sympathomimetics / pharmacology

Substances

  • Adrenergic beta-Antagonists
  • Catecholamines
  • Sympatholytics
  • Sympathomimetics
  • Interleukin-10
  • Propranolol